Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of 13vPnC in Indian Adults and Children
NCT02034877Phase 4Completed
- Sponsor
- Pfizer
- Start
- Aug 2014
- Primary completion
- Jul 2015
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of Prevnar 13 in Pneumococcal pneumonia (PP), invasive pneumococcal disease (IPD), sponsored by Pfizer. Started Aug 2014; status: completed.
02
Drugs
Prevnar 13
03
Conditions
Pneumococcal pneumonia (PP)invasive pneumococcal disease (IPD)
Beyond the preview
Go deeper on NCT02034877.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02034877.